Amarin Corp Plc (AMRN)

[couldbebetter]

I believe it may be because they are not seeking a Cardiovascular
label. What bothers me is that they are attempting to get their
EPA drug approved for COVID-19 use. THAT SHOULD CAUSE AMRN
MANAGEMENT SLEEPLESS NIGHTS. AMRN should be requesting emergency
approval of Vascepa in Europe to make it available in Europe ASAP!

Imagine (now I am moving into fantasy land here) if a BP such as
Roche or Novartis both of which are headquartered in Switzerland,
went to the EMA and suggest that if they agree to acquire AMRN
would they receive emergency approval to launch or at a minimum
get all the resources in place to insure a massive launch to make
certain Vascepa is available to as many people in Europe as possible.

This is my "dream" scenario. Impossible! Right???